<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:35:17Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:2757994" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:2757994</identifier><datestamp>2009-10-13</datestamp><setSpec>jbc</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Biol Chem</journal-id>
      <journal-id journal-id-type="hwp">jbc</journal-id>
      <journal-id journal-id-type="pmc">jbc</journal-id>
      <journal-id journal-id-type="publisher-id">JBC</journal-id>
      <journal-title-group>
        <journal-title>The Journal of Biological Chemistry</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0021-9258</issn>
      <issn pub-type="epub">1083-351X</issn>
      <publisher>
        <publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name>
        <publisher-loc>9650 Rockville Pike, Bethesda, MD 20814, U.S.A.</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC2757994</article-id>
      <article-id pub-id-type="pmcid">PMC2757994</article-id>
      <article-id pub-id-type="pmc-uid">2757994</article-id>
      <article-id pub-id-type="pmid">19617354</article-id>
      <article-id pub-id-type="pmid">19617354</article-id>
      <article-id pub-id-type="publisher-id">M109.011627</article-id>
      <article-id pub-id-type="doi">10.1074/jbc.M109.011627</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Protein Structure and Folding</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Fibulin 5 Forms a Compact Dimer in Physiological Solutions<xref ref-type="fn" rid="FN1">*</xref><xref ref-type="fn" rid="FN2"><sup><inline-graphic xlink:href="sbox.jpg"/></sup></xref></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Jones</surname>
            <given-names>Richard P. O.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>â¡</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Ming-Chuan</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>Â§</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jowitt</surname>
            <given-names>Thomas A.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>Â§</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ridley</surname>
            <given-names>Caroline</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>Â§</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mellody</surname>
            <given-names>Kieran T.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>Â§</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Howard</surname>
            <given-names>Marjorie</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>Â§</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Tao</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>â¡</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bishop</surname>
            <given-names>Paul N.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>â¡</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>Â§</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lotery</surname>
            <given-names>Andrew J.</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>Â¶</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kielty</surname>
            <given-names>Cay M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>Â§</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Baldock</surname>
            <given-names>Clair</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>Â§</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Trump</surname>
            <given-names>Dorothy</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>â¡</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>1</sup>
          </xref>
        </contrib>
        <aff id="aff1">From <label>â¡</label>Genetic Medicine, Manchester Academic Health Science Centre, Faculty of Medical and Human Sciences, and </aff>
        <aff id="aff2">the <label>Â§</label>Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, University of Manchester, Manchester M13 9PL and </aff>
        <aff id="aff3">the <label>Â¶</label>Clinical Neurosciences Division, University of Southampton, Southampton SO17 1BJ, United Kingdom</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><label>1</label> To whom correspondence should be addressed: <addr-line>Genetic Medicine, University of Manchester, Manchester Academic Health Science Centre, St Mary's Hospital, Oxford Rd., Manchester M13 9WL, UK.</addr-line> Fax: <fax>44-161-276-6606</fax>; E-mail: <email>dorothy.trump@manchester.ac.uk</email>.</corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>18</day>
        <month>9</month>
        <year>2009</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>7</month>
        <year>2009</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>17</day>
        <month>7</month>
        <year>2009</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. -->
      <volume>284</volume>
      <issue>38</issue>
      <fpage>25938</fpage>
      <lpage>25943</lpage>
      <history>
        <date date-type="received">
          <day>22</day>
          <month>4</month>
          <year>2009</year>
        </date>
        <date date-type="rev-recd">
          <day>9</day>
          <month>7</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© 2009 by The American Society for Biochemistry and Molecular Biology, Inc.</copyright-statement>
        <license license-type="open-access">
          <license-p><italic>Author's Choice</italic>âFinal version full access.</license-p>
          <license-p><ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">Creative Commons Attribution Non-Commercial License</ext-link> applies to Author Choice Articles</license-p>
        </license>
      </permissions>
      <self-uri xlink:title="pdf" xlink:type="simple" xlink:href="zbc03809025938.pdf"/>
      <abstract>
        <p>Fibulin 5 is a 52-kDa calcium-binding epidermal growth factor (cbEGF)-rich extracellular matrix protein that is essential for the formation of elastic tissues. Missense mutations in fibulin 5 cause the elastin disorder cutis laxa and have been associated with age-related macular degeneration, a leading cause of blindness. We investigated the structure, hydrodynamics, and oligomerization of fibulin 5 using small angle x-ray scattering, EM, light scattering, circular dichroism, and sedimentation. Compact structures for the monomer were determined by small angle x-ray scattering and EM, and are supported by close agreement between the theoretical sedimentation of the structures and the experimental sedimentation of the monomer in solution. EM showed that monomers associate around a central cavity to form a dimer. Light scattering and equilibrium sedimentation demonstrated that the equilibrium between the monomer and the dimer is dependent upon NaCl and Ca<sup>2+</sup> concentrations and that the dimer is dominant under physiological conditions. The dimerization of fragments containing just the cbEGF domains suggests that intermolecular interactions between cbEGFs cause dimerization of fibulin 5. It is possible that fibulin 5 functions as a dimer during elastinogenesis or that dimerization may provide a method for limiting interactions with binding partners such as tropoelastin.</p>
      </abstract>
    </article-meta>
  </front>
  <body><p>Fibulins are a family of seven extracellular matrix glycoproteins, some of which associate with elastic fibers and basement membranes (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). They are involved in the assembly, organization, and stabilization of macromolecular complexes (<xref ref-type="bibr" rid="B3">3</xref>). Fibulins contain arrays of cbEGF<xref ref-type="fn" rid="FN3"><sup>2</sup></xref>-like domains and a fibulin-type C-terminal (Fc) module (<xref ref-type="bibr" rid="B4">4</xref>). Fibulins 3â5 have a modified N-terminal cbEGF domain, followed by five cbEGF domains (<xref ref-type="bibr" rid="B4">4</xref>).</p><p>Fibulin 5 (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M109.011627/DC1">supplemental Fig. S1</ext-link>) is highly expressed in developing arteries with a low expression in adult vessels that is up-regulated following vascular injury and in atherosclerosis (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). Expression has been detected in other elastin-rich tissues, including aorta, skin, uterus, lung, heart, ovary, and colon (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). The extensibility of such tissues is provided by elastic fibers (<xref ref-type="bibr" rid="B7">7</xref>), and aging is associated with a loss of elasticity (<xref ref-type="bibr" rid="B8">8</xref>). Fibulin 5 is essential for elastinogenesis. The fibulin 5 knock-out mouse exhibits disorganized elastic fibers resulting in severe elastinopathies, with loose skin, vascular abnormalities, and emphysematous lungs. Similar changes are seen in an aged phenotype (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>). Mutations in fibulin 5 lead to the elastin disorder cutis laxa (<xref ref-type="bibr" rid="B11">11</xref><xref ref-type="bibr" rid="B12"/>â<xref ref-type="bibr" rid="B13">13</xref>) and have been associated with age-related macular degeneration (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>).</p><p>It has been shown that fibulin 5 binds elastic fibers (<xref ref-type="bibr" rid="B16">16</xref>) and interacts with tropoelastin (<xref ref-type="bibr" rid="B10">10</xref>), fibrillin 1 (<xref ref-type="bibr" rid="B17">17</xref>), lysyl oxidase-like protein 1 (<xref ref-type="bibr" rid="B18">18</xref>), -2, and -4 (<xref ref-type="bibr" rid="B19">19</xref>), latent transforming growth factor-Î²-binding protein 2 (<xref ref-type="bibr" rid="B19">19</xref>), emilin 1 (<xref ref-type="bibr" rid="B20">20</xref>), apolipoprotein (a) (<xref ref-type="bibr" rid="B21">21</xref>), and superoxide dismutase (<xref ref-type="bibr" rid="B22">22</xref>). Through an RGD motif fibulin 5 interacts with integrins (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B23">23</xref>).</p><p>The assembly of elastic fibers is a complex hierarchical process. A model proposes that fibulin 5 associates with microfibrils via interactions with fibrillin 1; tropoelastin molecules bind fibulin 5 and coacervate, and lysyl oxidase-like protein 1 enzymes cross-link tropoelastin to form mature elastin (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B16">16</xref>). Data that support this model indicate that fibulin 5 potentially increases the coacervation of tropoelastin, enhancing elastic fiber formation (<xref ref-type="bibr" rid="B24">24</xref>). However, other data suggest that fibulin 5 slows the maturation of elastin assemblies (<xref ref-type="bibr" rid="B25">25</xref>).</p><p>Rotary-shadowing EM has suggested that fibulin 5 exists as a short rod with a globular domain at one end (<xref ref-type="bibr" rid="B26">26</xref>). We used size-exclusion column multiangle laser light scattering (SEC-MALLS), small angle x-ray scattering (SAXS), EM single particle analysis, analytical ultracentrifugation (AUC), CD, and isoelectric focusing to investigate the structures of fibulin 5 in monomeric and dimeric form, and the equilibrium between the two forms.</p><sec sec-type="methods"><title>EXPERIMENTAL PROCEDURES</title><sec><title>Molecular Biology</title><p>The synthesis of the pCEP-His construct encoding full-length fibulin 5 was described previously (<xref ref-type="bibr" rid="B17">17</xref>). cDNAs encoding fragments of fibulin 5 and incorporating 5â² XhoI and 3â² NaeI restriction sites were obtained by PCR using the primers listed (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M109.011627/DC1">supplemental Fig. S2</ext-link>). The restriction sites enabled directional in-frame subcloning of the cDNAs at the 3â² end of the 6-histidine tag coding sequence in the pCEP-His vector. Correct in-frame transition and coding was confirmed by in-house DNA sequencing.</p></sec><sec><title>Purification of Recombinant Fibulin 5</title><p>Recombinant proteins were expressed by EBNA 293 cells stably transfected with pCEP-His constructs (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B23">23</xref>) and secreted into serum-free medium (SAFC Biosciences). The polypeptides were purified by Ni<sup>2+</sup>-affinity chromatography and applied to a Superdex 200 SEC (GE Healthcare). The following SEC buffers were used: buffer A, 50 m<sc>m</sc> Tris, pH 7.4, 0.5 <sc>m</sc> NaCl, 50 m<sc>m</sc> arginine, 50 m<sc>m</sc> glutamate (<xref ref-type="bibr" rid="B27">27</xref>), 5 m<sc>m</sc> EDTA, 5 m<sc>m</sc> EGTA; buffer B, 10 m<sc>m</sc> Tris, pH 7.4, 0.5 <sc>m</sc> NaCl, 2 m<sc>m</sc> EDTA, 2 m<sc>m</sc> EGTA; buffer C, 10 m<sc>m</sc> Tris, pH 7.4, 0.5 <sc>m</sc> NaCl; and buffer D, 10 m<sc>m</sc> Tris, pH 7.4, 0.5 <sc>m</sc> NaCl, 2 m<sc>m</sc> CaCl<sub>2</sub>.</p></sec><sec><title>MALLS</title><p>The SEC eluate passed through an EOS 18-angle light scattering detector equipped with a 688 nm laser to determine masses, a quasi-elastic light scattering detector to determine hydrodynamic radii, and an r-EX refractometer to determine protein concentrations (all from Wyatt Technology Corp.).</p></sec><sec><title>EM Structures of Full-length Fibulin 5</title><p>EM structures were determined for monomeric fibulin 5 in the absence of Ca<sup>2</sup>, and dimeric fibulin 5 in the presence of Ca<sup>2+</sup>.</p><sec><title/><sec><title>Grid Preparation</title><p>Carbon-coated 400-mesh copper grids underwent glow-discharge (EMITECH, mode K100X, 25 mA for 30 s) prior to the adsorption of fibulin 5 samples. The grids were negatively stained with 10 Î¼l of 4% (w/v) uranyl acetate for 30 s and lightly blotted.</p></sec><sec><title>Microscopy</title><p>Images were obtained using a Tecnai 12 (120 keV) microscope (Philips) with a LaB6 filament. Images were recorded at 52,000 magnification by a CCD camera (Tietz Video and Image Processing Systems TemCam, resolution 2000 Ã 2000) using low electron doses (&lt;10 e/Ã<sup>2</sup>) at the defocus value 2 Î¼m. The final image pixel size was 1.9 Ã.</p></sec><sec><title>Image Processing and Three-dimensional Reconstruction</title><p>The analysis of 6266 and 3052 single particles of size 19 and 22.8 nm<sup>2</sup> for the monomer and dimer, respectively, was performed using EMAN (<xref ref-type="bibr" rid="B28">28</xref>), Imagic 5 (<xref ref-type="bibr" rid="B29">29</xref>), and SPIDER software (<xref ref-type="bibr" rid="B30">30</xref>). Particles were aligned reference-free, and images were assigned to 120 and 80 classes that represented distinct views of the monomer and dimer, respectively. Preliminary three-dimensional structures were calculated by averaging the images in a class, using a Fourier common lines routine to determine the relative orientation of the classes, and then combining the classes. Assuming only <italic>c</italic><sub>1</sub> symmetry, the structures were refined iteratively with 8 cycles of projection matching, and the convergence of the Fourier shell correlation coefficient was monitored. Application of the Fourier shell correlation coefficient = 0.5 criterion gave three-dimensional volume resolutions of 17 and 22 Ã for the monomer and dimer, respectively.</p></sec></sec></sec><sec><title>SAXS Structure of Monomeric Full-length Fibulin 5</title><p>SAXS data were collected for fibulin 5 in the absence of Ca<sup>2+</sup> (buffer A) on beamline X33 at the Deutsches Elektronen-Synchrotron (DESY, Hamburg, Germany) (<xref ref-type="bibr" rid="B31">31</xref>) using a 120-s exposure time and a 2.4-m sample detector distance to cover a momentum transfer interval 0.01 Ã<sup>â1</sup> &lt; <italic>q</italic> &lt; 0.5 Ã<sup>â1</sup> (where <italic>q</italic> = 4ÏsinÎ¸/Î», where 2Î¸ is the angle between the incident and scattered radiation). Buffer scattering intensities were subtracted from the sample scattering data. <italic>R<sub>g</sub></italic> and <italic>D</italic><sub>max</sub> values were evaluated with the indirect Fourier transform program Gnom (<xref ref-type="bibr" rid="B32">32</xref>). Particle shapes were restored <italic>ab initio</italic> based on the simulated annealing algorithm using Gasbor (<xref ref-type="bibr" rid="B33">33</xref>): Twenty runs generated similar shapes that were combined and filtered to produce an average model using the Damaver (<xref ref-type="bibr" rid="B34">34</xref>) software.</p></sec><sec><title>CD</title><p>Buffer-corrected CD spectra were measured between 190 and 260 nm by a J-810 spectropolarimeter (Jasco) using a 0.05-cm path length and an average of 10 scans. Spectra were deconvoluted by the Dichroweb (<xref ref-type="bibr" rid="B35">35</xref>) on-line server running the CDSSTR software (<xref ref-type="bibr" rid="B36">36</xref>) with reference set 7.</p></sec><sec><title>AUC of Full-length Fibulin 5</title><p>The Sednterp (<xref ref-type="bibr" rid="B37">37</xref>) software calculated buffer densities and viscosities, a mass of 49,779 Da, standard partial specific volume (PSV) of 0.7085 ml/g, and hydration of 0.3802 g (H<sub>2</sub>O)/g (protein) for the recombinant fibulin 5 amino acid sequence. The MALLS-derived mass of 51,620 Da for the glycosylated fibulin 5 polypeptide and the estimate of 0.6170 ml/g for the PSV of carbohydrate (<xref ref-type="bibr" rid="B38">38</xref>) were used to calculate the estimate 0.7052 ml/g for the PSV for the glycosylated fibulin 5 polypeptide that was used in subsequent Sednterp (<xref ref-type="bibr" rid="B37">37</xref>) calculations. Sedimentation experiments were performed in an Optima XL-A analytical ultracentrifuge (Beckman Coulter) equipped with an absorbance optical system.</p><sec><title/><sec><title>Sedimentation Velocity</title><p>Sample and buffer were centrifuged in a two-sector centerpiece in an An-60 Ti 4-hole rotor at 45,000 rpm at 20 Â°C. The sedimentation was monitored at 230 nm by 150 scans across a 1.4-cm radius with a step size of 0.003 cm. Sedfit (<xref ref-type="bibr" rid="B39">39</xref>) performed Lamm equation boundary modeling to calculate size <italic>c</italic>(<italic>s</italic>) and mass <italic>c</italic>(<italic>M</italic>) distributions. Sednterp (<xref ref-type="bibr" rid="B37">37</xref>) used S values for <italic>c</italic>(<italic>s</italic>) maxima to calculate standard sedimentation coefficient <italic>s</italic><sub>20,<italic>w</italic></sub> values and hydrodynamic radii <italic>R<sub>H</sub></italic> values.</p></sec><sec><title>Sedimentation Equilibrium</title><p>Sedimentation equilibrium experiments determined the [NaCl] dependence of the AM/MM ratio and the dimer dissociation constant <italic>K<sub>d</sub></italic> in the absence of Ca<sup>2+</sup> and the [Ca<sup>2+</sup>] dependence of AM/MM and <italic>K<sub>d</sub></italic> for fibulin 5 in 150 m<sc>m</sc> NaCl. Each six-sector centerpiece contained solutions with only one cation concentration combination but three protein concentrations at 0.4, 2.4, and 2.5 Î¼<sc>m</sc> corresponding to absorbances at 230 nm of â¼ 0.5, 1, and 2, respectively; protein-free reference solutions of the same cation composition occupied the remaining three spaces in each centerpiece. The centerpieces were centrifuged in an An-50 Ti 8-hole rotor at 4 Â°C at sequential speeds 8000, 15,000, and 20,000 rpm. At each speed, 14 h allowed the sedimentation to reach equilibrium before data were collected. Twenty replicate scans with the maximum radial resolution of 0.001 cm were acquired at wavelengths 230, 235, and 280 nm. Global data analysis was performed by the Sedphat software (<xref ref-type="bibr" rid="B40">40</xref>).</p></sec></sec></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title/><sec><title/><sec><title>Purification and Glycosylation of Fibulin 5 Polypeptides</title><p>Full-length fibulin 5 (residues 27â448), and the fragments of fibulin 5 that included residues 26â333 (cbEGF-like domains 1â6), 120â333 and 127â333 (cbEGFs 2â6), 127â287 (cbEGFs 2â5), and 342â448 (the Fc domain) were purified from media to homogeneity by Ni<sup>2+</sup>-affinity chromatography. The purified polypeptides were applied to SDS-PAGE followed by staining with Coomassie Blue (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M109.011627/DC1">supplemental Fig. S3<italic>A</italic></ext-link>). Amounts of the fragment comprising residues 342â448 were insufficient to be detected by Coomassie staining of acrylamide gels following Ni<sup>2+</sup>-affinity purification and were later shown to elute at the void of the SEC in buffer C, suggesting aggregation (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M109.011627/DC1">supplemental Fig. S3<italic>D</italic></ext-link>). This fragment was not investigated further.</p><p>Fibulin 5 contains two potential <italic>N</italic>-linked glycosylation sites at residues 283 and 296 in cbEGF 5 and cbEGF 6, respectively. The glycosylation of recombinant fibulins has been demonstrated previously (<xref ref-type="bibr" rid="B26">26</xref>). A Western blot following treatment with (+) or without (â) <italic>N</italic>-glycosidase (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M109.011627/DC1">supplemental Fig. S3<italic>B</italic></ext-link>) showed that the EBNA 293 cells glycosylated the full-length polypeptide and fragments 26â333 and 120â333. The MALLS-derived masses for all polypeptides that contained one or more glycosylation sites were larger than those calculated by Sednterp (<xref ref-type="bibr" rid="B37">37</xref>) from the primary amino acid sequences (<xref ref-type="table" rid="T1">Table 1</xref> and <ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M109.011627/DC1">supplemental Fig. S4</ext-link>).</p><table-wrap id="T1" position="float"><label>TABLE 1</label><caption><p><bold>Hydrodynamic parameters for full-length fibulin 5 monomers, dimers, and HOOs were determined from the analysis of solution (sol)(MALLS, AUC, and SAXS) and EM data as indicated</bold></p><p><italic>D</italic><sub>max</sub> is the maximum dimension. The means and standard errors shown were calculated from results for three batches of protein.</p></caption><table frame="hsides" rules="groups"><thead valign="bottom"><tr><th align="center" rowspan="1" colspan="1">Ca<sup>2+</sup></th><th align="center" rowspan="1" colspan="1">Fibulin 5 oligomer</th><th align="center" rowspan="1" colspan="1">Mass</th><th align="center" rowspan="1" colspan="1"><italic>f</italic>/<italic>f</italic><sub>0</sub><xref ref-type="table-fn" rid="TF1-1"><italic><sup>a</sup></italic></xref></th><th align="center" rowspan="1" colspan="1"><italic>f</italic>/<italic>f</italic><sub>0</sub><xref ref-type="table-fn" rid="TF1-2"><italic><sup>b</sup></italic></xref></th><th align="center" rowspan="1" colspan="1"><italic>s</italic><sub>20,</sub><italic><sub>w</sub></italic> (Ã10<sup>13</sup> S)</th><th align="center" rowspan="1" colspan="1"><italic>R<sub>H</sub></italic></th><th align="center" rowspan="1" colspan="1"><italic>D</italic><sub>max</sub></th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><italic>kDa</italic></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><italic>nm</italic></td><td align="center" rowspan="1" colspan="1"><italic>nm</italic></td></tr><tr><td align="left" rowspan="3" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1"><sup>sol</sup>monomer</td><td align="char" char="Â±" rowspan="1" colspan="1">51.6 Â± 0.4<xref ref-type="table-fn" rid="TF1-3"><italic><sup>c</sup></italic></xref></td><td align="char" char="Â±" rowspan="1" colspan="1">1.46 Â± 0.05</td><td align="char" char="Â±" rowspan="1" colspan="1">1.48 Â± 0.01</td><td align="char" char="Â±" rowspan="1" colspan="1">3.73 Â± 0.02<xref ref-type="table-fn" rid="TF1-2"><italic><sup>b</sup></italic></xref></td><td align="char" char="Â±" rowspan="1" colspan="1">3.61 Â± 0.02<xref ref-type="table-fn" rid="TF1-2"><italic><sup>b</sup></italic></xref></td><td rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><sup>SAXS</sup>monomer</td><td align="char" char="." rowspan="1" colspan="1">51.6<xref ref-type="table-fn" rid="TF1-4"><italic><sup>d</sup></italic></xref></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">3.80<xref ref-type="table-fn" rid="TF1-5"><italic><sup>e</sup></italic></xref></td><td align="char" char="." rowspan="1" colspan="1">3.54<xref ref-type="table-fn" rid="TF1-5"><italic><sup>e</sup></italic></xref></td><td align="char" char="." rowspan="1" colspan="1">13<xref ref-type="table-fn" rid="TF1-5"><italic><sup>e</sup></italic></xref></td></tr><tr><td align="center" rowspan="1" colspan="1"><sup>EM</sup>monomer</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">3.79<xref ref-type="table-fn" rid="TF1-6"><italic><sup>f</sup></italic></xref></td><td align="char" char="." rowspan="1" colspan="1">3.55<xref ref-type="table-fn" rid="TF1-6"><italic><sup>f</sup></italic></xref></td><td align="char" char="." rowspan="1" colspan="1">10<xref ref-type="table-fn" rid="TF1-6"><italic><sup>f</sup></italic></xref></td></tr><tr><td align="left" rowspan="5" colspan="1">Present</td><td align="center" rowspan="1" colspan="1"><sup>sol</sup>monomer</td><td align="char" char="." rowspan="1" colspan="1">51.6<xref ref-type="table-fn" rid="TF1-4"><italic><sup>d</sup></italic></xref></td><td rowspan="1" colspan="1"/><td align="char" char="Â±" rowspan="1" colspan="1">1.55 Â± 0.07</td><td align="char" char="Â±" rowspan="1" colspan="1">3.6 Â± 0.2<xref ref-type="table-fn" rid="TF1-2"><italic><sup>b</sup></italic></xref></td><td align="char" char="Â±" rowspan="1" colspan="1">3.8 Â± 0.2<xref ref-type="table-fn" rid="TF1-2"><italic><sup>b</sup></italic></xref></td><td rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><sup>sol</sup>dimer</td><td align="char" char="." rowspan="1" colspan="1">103.2<xref ref-type="table-fn" rid="TF1-4"><italic><sup>d</sup></italic></xref></td><td align="char" char="Â±" rowspan="1" colspan="1">1.3 Â± 0.1</td><td align="char" char="Â±" rowspan="1" colspan="1">1.64 Â± 0.07</td><td align="char" char="Â±" rowspan="1" colspan="1">5.3 Â± 0.2<xref ref-type="table-fn" rid="TF1-2"><italic><sup>b</sup></italic></xref></td><td align="char" char="Â±" rowspan="1" colspan="1">5.0 Â± 0.2<xref ref-type="table-fn" rid="TF1-2"><italic><sup>b</sup></italic></xref></td><td rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><sup>EM</sup>dimer</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">5.31<xref ref-type="table-fn" rid="TF1-6"><italic><sup>f</sup></italic></xref></td><td align="char" char="." rowspan="1" colspan="1">5.07<xref ref-type="table-fn" rid="TF1-6"><italic><sup>f</sup></italic></xref></td><td align="char" char="." rowspan="1" colspan="1">15<xref ref-type="table-fn" rid="TF1-6"><italic><sup>f</sup></italic></xref></td></tr><tr><td align="center" rowspan="1" colspan="1"><sup>sol</sup>HOOs</td><td align="center" rowspan="1" colspan="1">200â1000<xref ref-type="table-fn" rid="TF1-3"><italic><sup>c</sup></italic></xref></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&lt;1000<xref ref-type="table-fn" rid="TF1-7"><italic><sup>g</sup></italic></xref></td><td align="char" char="." rowspan="1" colspan="1">1.48</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TF1-1"><p><italic><sup>a</sup></italic> Sedfit (<xref ref-type="bibr" rid="B39">39</xref>) determined the best fit for mass-independent frictional ratio <italic>f</italic>/<italic>f</italic><sub>0</sub>.</p></fn><fn id="TF1-2"><p><italic><sup>b</sup></italic> Sednterp (<xref ref-type="bibr" rid="B37">37</xref>) used the MALLS-derived mass and the S values for <italic>c</italic>(<italic>s</italic>) maxima to calculate <italic>f/f</italic><sub>0</sub>, standard sedimentation coefficient <italic>s</italic><sub>20,</sub><italic><sub>w</sub></italic> and hydrodynamic radius <italic>R<sub>H</sub></italic>.</p></fn><fn id="TF1-3"><p><italic><sup>c</sup></italic> Mass was derived from MALLS.</p></fn><fn id="TF1-4"><p><italic><sup>d</sup></italic> Mass was calculated from the MALLS-derived mass of the monomer.</p></fn><fn id="TF1-5"><p><italic><sup>e</sup></italic> Hydropro (<xref ref-type="bibr" rid="B43">43</xref>) calculated theoretical standard hydrodynamic parameters for the SAXS monomer structure.</p></fn><fn id="TF1-6"><p><italic><sup>f</sup></italic> Hydromic (<xref ref-type="bibr" rid="B42">42</xref>) calculated theoretical standard hydrodynamic parameters for the EM structures.</p></fn><fn id="TF1-7"><p><italic><sup>g</sup></italic> Mass range was estimated from the c(<italic>M</italic>) distribution (S7B), which depends upon <italic>f/f</italic><sub>0</sub>.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Folding</title><p>CD spectra were measured for the cbEGF-containing fragments in buffer C and for full-length fibulin 5 in three buffers (BâD) to determine the Ca<sup>2+</sup> dependence of folding. The CD spectra (<xref ref-type="fig" rid="F1">Fig. 1</xref><italic>A</italic> and <ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M109.011627/DC1">supplemental Fig. S5<italic>A</italic></ext-link>) show that all of the polypeptides are folded in all of the buffers and display minima at â¼ 205 nm between characteristic minima at 198 nm for unordered structure and at 216 nm for Î²-strand (<xref ref-type="bibr" rid="B41">41</xref>). Deconvolution of the spectra by CDSSTR software (<xref ref-type="bibr" rid="B36">36</xref>) provided estimates of secondary structure content (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M109.011627/DC1">supplemental Fig. S6</ext-link>) that ranked unordered &gt; strand &gt; turn &gt; helix. The high unordered contents may reflect that cbEGFs are small, tightly folded domains locked by internal disulfide bonds without extended regions of âconventionalâ secondary structures. A Student's <italic>t</italic> test (4 degrees of freedom, <italic>p</italic> &lt; 0.05) showed the fits (indicated by normalized root mean square deviation (<xref ref-type="bibr" rid="B35">35</xref>)) of the CD spectra for full-length fibulin 5 were worse when Ca<sup>2+</sup> was present. This may reflect the Ca<sup>2+</sup>-induced âsettingâ of the cbEGFs into a more rigid structure with less well modeled secondary structure. However, statistically significant differences in secondary structure contents for full-length fibulin 5 in different buffers were not detected.</p><fig id="F1" position="float"><label>FIGURE 1.</label><caption><p><bold>CD, SEC-MALLS, and velocity sedimentation for full-length fibulin 5.</bold> <italic>A</italic>, mean CD spectra for three batches of fibulin 5 purified by SEC in each buffer. <italic>B</italic> and <italic>C</italic>, chromatograms show the dependence of the differential refractive index (<italic>DRI</italic>) upon [NaCl] and [Ca<sup>2+</sup>]. The DRI was normalized to 1.0 for each peak maximum; the column void positions were co-registered at 8 ml. <italic>B</italic>, first applications of fibulin 5 to the SEC. <italic>C</italic>, selected fractions were reapplied to SEC-MALLS to determine molar masses. <italic>D</italic>, sedimentation of SEC-purified fractions of fibulin 5 in the absence (<italic>red line</italic>, monomer) and presence (<italic>black line</italic>, mainly dimer) of Ca<sup>2+</sup>. <italic>c</italic>(<italic>s</italic>) size distributions were calculated by Sedfit (<xref ref-type="bibr" rid="B39">39</xref>).</p></caption><graphic xlink:href="zbc0410988810001"/></fig></sec><sec><title>Ca<sup>2+</sup>-dependent Oligomerization</title><p>The full-length fibulin 5 polypeptide was analyzed by size-exclusion chromatography in four different buffers (<xref ref-type="fig" rid="F1">Fig. 1</xref><italic>B</italic>). In the absence of Ca<sup>2+</sup> there was a peak at 14 ml and a second peak at the void volume (8 ml) that was assumed to be aggregate. The presence of 2 m<sc>m</sc> Ca<sup>2+</sup> caused a left shift of the main peak to 13 ml, the appearance of a continuum, and a second maximum at 10 ml. Increasing the salt concentration to 500 m<sc>m</sc> decreased the amount of aggregate in the void volume, and so 500 m<sc>m</sc> salt buffers were used for subsequent MALLS, CD, and sedimentation velocity experiments.</p><p>Chromatograms (<xref ref-type="fig" rid="F1">Fig. 1</xref><italic>C</italic>) show the reapplication of selected SEC fractions to the SEC equilibrated in the same buffer so that molar masses could be determined from the MALLS data in the absence of base-line interference from the column-void peak. In the absence of Ca<sup>2+</sup> (buffer B), the reapplication to the SEC of the elution fraction 14â14.5 ml (<italic>red line</italic>, <xref ref-type="fig" rid="F1">Fig. 1</xref><italic>B</italic>) produced a single peak centered at 14.4 ml (<italic>red line</italic>, <xref ref-type="fig" rid="F1">Fig. 1</xref><italic>C</italic>) due entirely to monomeric fibulin 5, as shown by the flat trace of calculated masses (<italic>red crosses</italic>, <xref ref-type="fig" rid="F1">Fig. 1</xref><italic>C</italic>). The mean of average masses determined for three batches of monomer 51.6 Â± 0.4 kDa enabled the calculation of a modified PSV (<xref ref-type="bibr" rid="B38">38</xref>) for the glycosylated full-length polypeptide that was used in the AUC analyses. In the presence of Ca<sup>2+</sup> (buffer D), the reapplication to the SEC of the elution fraction 13â13.5 ml (<italic>black line</italic>, <xref ref-type="fig" rid="F1">Fig. 1</xref><italic>B</italic>) gave a broader peak centered at 13.7 ml that contained both monomeric and dimeric forms (<italic>black line</italic>, <xref ref-type="fig" rid="F1">Fig. 1</xref><italic>C</italic>). The SEC fraction 13â13.5 ml containing mainly the dimeric form was run on SDS-PAGE under both reducing and nonreducing conditions, and a Western blot (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M109.011627/DC1">supplemental Fig. S3<italic>C</italic></ext-link>) showed that dimerization is not mediated by intermolecular disulfide bonds. This suggests, as expected, that all cysteines are involved in intramolecular disulfide bonds that stabilize a correctly folded structure. Also in the presence of Ca<sup>2+</sup> (buffer D), the reapplication to the SEC of the elution fraction 10â10.5 ml (<italic>black line</italic>, <xref ref-type="fig" rid="F1">Fig. 1</xref><italic>B</italic>) gave a peak centered at 10.5 ml (<italic>black line</italic>, <xref ref-type="fig" rid="F1">Fig. 1</xref><italic>C</italic>) with the estimated mass range 200â1000 kDa. This peak includes higher order oligomers (HOOs) estimated to range from a tetramer to a 20-mer.</p><p>Selected fractions collected during the first SEC runs in the presence (buffer D) and absence (buffer B) of Ca<sup>2+</sup> underwent velocity sedimentation, and (mass-independent) frictional ratios (<italic>f</italic>/<italic>f</italic><sub>0</sub>) (<xref ref-type="table" rid="T1">Table 1</xref>) and hence <italic>c</italic>(<italic>s</italic>) distributions (<xref ref-type="fig" rid="F1">Fig. 1</xref><italic>D</italic>) were calculated by Sedfit (<xref ref-type="bibr" rid="B39">39</xref>). In the absence of Ca<sup>2+</sup>, the <italic>c</italic>(<italic>s</italic>) had a maximum at 3.36 S that was assigned as monomer. In the presence of Ca<sup>2+</sup>, the <italic>c</italic>(<italic>s</italic>) was dominated by a maximum at 5.2 S that was assigned as a dimer, although small amounts of monomer and possibly trimer were also visible. Sednterp (<xref ref-type="bibr" rid="B37">37</xref>) used the MALLS-derived masses and the S values for <italic>c</italic>(<italic>s</italic>) maxima to calculate <italic>f</italic>/<italic>f</italic><sub>0</sub>, <italic>s</italic><sub>20,</sub><italic><sub>w</sub></italic>, and <italic>R<sub>H</sub></italic> values (<xref ref-type="table" rid="T1">Table 1</xref>). For the monomer in the absence of Ca<sup>2+</sup>, agreement between the mass-dependent <italic>f</italic>/<italic>f</italic><sub>0</sub> calculated by Sednterp (<xref ref-type="bibr" rid="B37">37</xref>) and the mass-independent <italic>f</italic>/<italic>f</italic><sub>0</sub> calculated by Sedfit (<xref ref-type="bibr" rid="B39">39</xref>) provided confidence that both the MALLS-derived mass and the <italic>c</italic>(<italic>s</italic>) peak assignment are correct. Statistically significant differences between <italic>s</italic><sub>20,</sub><italic><sub>w</sub></italic> and <italic>R<sub>H</sub></italic> values for the monomer in the presence and absence of Ca<sup>2+</sup> were not detected. This suggests that any shape change is subtle.</p><p>The SEC fraction 10â10.5 ml (<italic>black line</italic>, <xref ref-type="fig" rid="F1">Fig. 1</xref><italic>B</italic>) containing fibulin 5 HOOs in the presence of Ca<sup>2+</sup> (buffer D) was subjected to velocity sedimentation, and Sedfit (<xref ref-type="bibr" rid="B39">39</xref>) calculated the <italic>c</italic>(<italic>s</italic>,*) distribution, which is independent of both masses and <italic>f</italic>/<italic>f</italic><sub>0</sub> values, and floated the <italic>f</italic>/<italic>f</italic><sub>0</sub> to obtain the <italic>c</italic>(<italic>s</italic>) distribution, which follows closely the <italic>c</italic>(<italic>s</italic>,*) distribution (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M109.011627/DC1">supplemental Fig. S7<italic>A</italic></ext-link>). It is intriguing that the <italic>f</italic>/<italic>f</italic><sub>0</sub>, a weighted average for the HOOs, is similar to those measured for the monomer (<xref ref-type="table" rid="T1">Table 1</xref>). This suggests that the shapes of the HOOs are not linear. Sedfit (<xref ref-type="bibr" rid="B39">39</xref>) converted the <italic>c</italic>(<italic>s</italic>) distribution into the <italic>c</italic>(<italic>M</italic>) distribution for the HOOs (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M109.011627/DC1">supplemental Fig. S7<italic>B</italic></ext-link>). The <italic>c</italic>(<italic>M</italic>) cut-off at â¼1000 kDa is consistent with the MALLS cut-off (<xref ref-type="table" rid="T1">Table 1</xref>).</p><p>Chromatograms (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M109.011627/DC1">supplemental Fig. S5<italic>B</italic></ext-link>) for first applications to the SEC equilibrated in buffer C show the oligomerization of fragments that contain only cbEGF domains. MALLS-derived masses for the fragment that includes residues 120â333 show that the peak at 14.9 ml is because of monomers, and the peak at 13.5 ml is because of dimers (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M109.011627/DC1">supplemental Fig. S5<italic>C</italic></ext-link>).</p><p>Sedimentation equilibrium experiments determined the dependence of the equilibrium between the monomer and the dimer upon [NaCl] and [Ca<sup>2+</sup>]. In the absence of calcium, increasing the [NaCl] to 150 m<sc>m</sc> produced an exponential growth of AM/MM, accompanied by an exponential decay in <italic>K<sub>d</sub></italic> (<xref ref-type="fig" rid="F2">Fig. 2</xref><italic>A</italic> and <ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M109.011627/DC1">supplemental Fig. S8</ext-link>). An explanation is that salt overcomes the electrostatic repulsion between monomers. The isoelectric point of 4.73 measured for glycosylated full-length fibulin 5 (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M109.011627/DC1">supplemental Fig. S9</ext-link>) agrees with the value 4.89 predicted for the primary amino acid sequence by Sednterp (<xref ref-type="bibr" rid="B37">37</xref>), which also predicts that each monomer has a charge of â28.7 at pH 7.3. Increasing the salt concentration further to 500 m<sc>m</sc> reduced the proportion of dimer, as is shown by <xref ref-type="fig" rid="F1">Fig. 1</xref><italic>C</italic>, where the peak at 14.5 ml is composed entirely of monomer. The equilibrium at 150 m<sc>m</sc> NaCl was shifted further toward the dimer on the addition of Ca<sup>2+</sup> (<xref ref-type="fig" rid="F2">Fig. 2</xref><italic>B</italic> and <ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M109.011627/DC1">supplemental Fig. S8</ext-link>).</p><fig id="F2" position="float"><label>FIGURE 2.</label><caption><p><bold>Equilibrium sedimentation of full-length fibulin 5.</bold> <italic>A</italic>, in the absence of Ca<sup>2+</sup> equilibrium sedimentation established the [NaCl] dependence of the dimer dissociation constant <italic>K<sub>d</sub></italic> and the ratio AM/MM. <italic>B</italic>, [Ca<sup>2+</sup>] dependence of <italic>K<sub>d</sub></italic> and AM/MM was determined for fibulin 5 in 150 m<sc>m</sc> NaCl. Data were analyzed by global nonlinear regression within Sedphat (<xref ref-type="bibr" rid="B40">40</xref>): Each <italic>error bar</italic> was determined by 100 Monte-Carlo simulations of the experimental data.</p></caption><graphic xlink:href="zbc0410988810002"/></fig></sec><sec><title>EM Structures for Monomeric and Dimeric Full-length Fibulin 5</title><p>Negatively stained images were obtained for monomeric fibulin 5 in the absence of Ca<sup>2+</sup> and dimeric fibulin 5 in the presence of Ca<sup>2+</sup>, and three-dimensional reconstructions were calculated. The Hydromic (<xref ref-type="bibr" rid="B42">42</xref>) software determined thresholds for which the calculated theoretical standard hydrodynamic parameters of the EM structures matched those parameters determined by sedimentation velocity experiments (<xref ref-type="table" rid="T1">Table 1</xref>). <xref ref-type="fig" rid="F3">Fig. 3</xref><italic>B</italic> displays projections of the EM structures with the Hydromic-derived thresholds.</p><fig id="F3" position="float"><label>FIGURE 3.</label><caption><p><bold>Structures of the fibulin 5 monomer in the absence of Ca<sup>2+</sup> and the dimer in the presence of Ca<sup>2+</sup>.</bold> <italic>A</italic>, selected representative class averages from EM single-particle image processing comparable with <italic>B</italic>, orthogonal views of the volume-rendered EM three-dimensional reconstructions. Thresholds were determined by matching theoretical standard hydrodynamic parameters calculated by Hydromic (<xref ref-type="bibr" rid="B42">42</xref>) for the reconstructions with experimentally measured parameters (<xref ref-type="table" rid="T1">Table 1</xref>). <italic>C</italic>, a âmost probableâ SAXS model for fibulin 5 is shown as touching spheres in orthogonal orientations.</p></caption><graphic xlink:href="zbc0410988810003"/></fig></sec><sec><title>SAXS Solution Structure of Monomeric Full-length Fibulin 5</title><p>X-ray scattering measurements were made on a solution of monomeric fibulin 5 in the absence of Ca<sup>2+</sup>. Aggregation was ruled out because the Guinier plot (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M109.011627/DC1">supplemental Fig. S10<italic>B</italic></ext-link>) was linear. The radius of gyration (<italic>R<sub>g</sub></italic>) was 4.20 Â± 0.04 nm. The structure of fibulin 5 was determined <italic>ab initio</italic> by sequential application of the Gnom (<xref ref-type="bibr" rid="B32">32</xref>) and Gasbor (<xref ref-type="bibr" rid="B33">33</xref>) programs that provided good and coincident fits of the raw scattering data (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M109.011627/DC1">supplemental Fig. S10<italic>A</italic></ext-link>). Twenty separate simulations of Gasbor (<xref ref-type="bibr" rid="B33">33</xref>) were run, and the average three-dimensional structure (<xref ref-type="fig" rid="F3">Fig. 3</xref><italic>C</italic>) was calculated using the Damaver software (<xref ref-type="bibr" rid="B34">34</xref>). Theoretical sedimentation of this structure by Hydropro (<xref ref-type="bibr" rid="B43">43</xref>) gave an <italic>s</italic><sub>20,</sub><italic><sub>w</sub></italic> and an <italic>R<sub>H</sub></italic> that agreed with values derived from velocity sedimentation experiments (<xref ref-type="table" rid="T1">Table 1</xref>).</p></sec></sec></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Fibulin 5 is a Ca<sup>2+</sup>-binding protein of critical importance in the assembly of elastic fibers, and mutations in the fibulin gene cause cutis laxa (<xref ref-type="bibr" rid="B11">11</xref><xref ref-type="bibr" rid="B12"/>â<xref ref-type="bibr" rid="B13">13</xref>) and have been implicated in age-related macular degeneration (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>). There are no high resolution structures for any of the fibulins, so knowledge of their structures is confined to comparisons with cbEGF-like domains for which high resolution structures exist (<xref ref-type="bibr" rid="B44">44</xref>). In the nonphysiological absence of Ca<sup>2+</sup>, our compact SAXS and EM structures for monomeric fibulin 5 agree with but improve upon previous lower resolution EM images (<xref ref-type="bibr" rid="B26">26</xref>). The appearance of the hole in the SAXS structure (<xref ref-type="fig" rid="F3">Fig. 3</xref><italic>C</italic>) might be explained if the Fc module folds back along a linear series of cbEGF repeats. Our EM structure of dimeric fibulin 5 in the presence of Ca<sup>2+</sup> suggests a head-to-tail arrangement of monomers. The dimerization of fragments that contain just the cbEGF domains suggest that intermolecular cbEGF interactions cause dimerization of full-length fibulin 5. It is likely that Ca<sup>2+</sup> mediates these interactions. It has previously been shown that Ca<sup>2+</sup> mediates contacts between identical human clotting factor IX cbEGFs in a crystal (<xref ref-type="bibr" rid="B45">45</xref>).</p><p>Fibulin 5 operates in the normal extracellular [Ca<sup>2+</sup>] range 1.0â1.25 m<sc>m</sc> and in 135â145 m<sc>m</sc> NaCl (<xref ref-type="bibr" rid="B46">46</xref>). We found that the fibulin 5 dimer concentration is dominant in physiological solutions and is buffered strongly by NaCl and Ca<sup>2+</sup> against changes in extracellular cation concentrations. A minimum dimer-dissociation constant of 0.86 Î¼<sc>m</sc> was reached in a 150 m<sc>m</sc> NaCl solution on the addition of only 0.5 m<sc>m</sc> Ca<sup>2+</sup>. The sensitivity of dimerization to Ca<sup>2+</sup>, the presence of 0.6 m<sc>m</sc> Ca<sup>2+</sup> in the media, and the acquisition of primarily monomeric fibulin 5 from Ni<sup>2+</sup>-affinity and size-exclusion chromatographies performed in the absence of both Ca<sup>2+</sup> and chelators (data not shown) suggest that dimers can dissociate. This is consistent with the picture of dynamic exchange between monomer and dimer populations drawn by the sedimentation data. Dissociation may explain why the maximum fraction of dimer is 0.7 rather than unity (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M109.011627/DC1">supplemental Fig. S8</ext-link>), but it does not explain why it is independent of Ca<sup>2+</sup> concentrations above 0.5 m<sc>m</sc>. The presence of low masses in the <italic>c</italic>(<italic>M</italic>) distribution (<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M109.011627/DC1">supplemental Fig. S7<italic>B</italic></ext-link>) suggests that higher order oligomers can also dissociate.</p><p>To date we have failed to crystallize fibulin 5, and this may be due to its flexibility and the [NaCl] and [Ca<sup>2+</sup>] dependence of oligomerization. Except by size-exclusion chromatography, it is difficult to obtain a homogeneous preparation of one oligomeric form, and the salts contained in many crystallization conditions may only increase heterogeneity. Binding calcium protects some cbEGF-rich proteins against proteolytic degradation (<xref ref-type="bibr" rid="B47">47</xref>). For fibulin 5, any such effect could be augmented by dimerization reducing access to proteolytic cleavage sites.</p><p>The elastogenesis functions of fibulin 5 may be affected by its oligomerization. It is possible that the monomer or the dimer or both are âactiveâ with regard to a function, but dimerization may provide a method for limiting interactions with binding partners. Binding studies should be reinterpreted in the light of equilibrium results presented here. For example, enhancement of the binding of fibulin 5 to tropoelastin by Ca<sup>2+</sup> (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B24">24</xref>) could result directly from Ca<sup>2+</sup>-mediated binding or indirectly from Ca<sup>2+</sup>-mediated conformational change or dimerization of fibulin 5. The experimental conditions (high salt in the absence of Ca<sup>2+</sup>) in the work of Cirulis <italic>et al.</italic> (<xref ref-type="bibr" rid="B25">25</xref>) suggest that monomeric fibulin 5 is responsible for elastin polypeptide self-assembly maturation slowing activity. It will be interesting to see how the Ca<sup>2+</sup>-bound dimer affects the maturation of elastin assemblies.</p></sec>
      <sec sec-type="supplementary-material">
         <title>Supplementary Material</title>
         <supplementary-material id="PMC_1" content-type="local-data">
            <caption>
               <title>Supplemental Data</title>
            </caption>
            <media mimetype="text" mime-subtype="html" xlink:href="supp_284_38_25938__index.html"/>
            <media xlink:role="associated-file" mimetype="application" mime-subtype="pdf" xlink:href="supp_M109.011627_jbc.M109.011627-1.pdf"/>
         </supplementary-material>
      </sec>
   </body>
  <back>
    <fn-group>
      <fn fn-type="supported-by" id="FN1">
        <label>*</label>
        <p>This work was supported by Wellcome Trust Grants 123364 (to D. T., A. J. L., P. N. B., C. M. K., R. P. O. J., and C. R.), 072291 (to C. B. and M. C. W.), and VIP award (to R. P. O. J., and D. T.), and the National Institute for Health Research, Manchester Biomedical Research Centre.</p>
      </fn>
      <fn fn-type="supplementary-material" id="FN2">
        <label>
          <inline-graphic xlink:href="sbox.jpg"/>
        </label>
        <p>The on-line version of this article (available at <ext-link ext-link-type="uri" xlink:href="http://www.jbc.org">http://www.jbc.org</ext-link>) contains <ext-link ext-link-type="uri" xlink:href="http://www.jbc.org/cgi/content/full/M109.011627/DC1">supplemental Figs. 1â10 and additional references</ext-link>.</p>
      </fn>
    </fn-group>
    <fn-group content-type="abbreviations">
      <fn id="FN3">
        <label>2</label>
        <p>The abbreviations used are:
<def-list><def-item><term id="G1">cbEGF</term><def><p>calcium-binding epidermal growth factor</p></def></def-item><def-item><term id="G2">SAXS</term><def><p>small angle x-ray scattering</p></def></def-item><def-item><term id="G3">Fc</term><def><p>fibulin-type C-terminal</p></def></def-item><def-item><term id="G4">SEC-MALLS</term><def><p>size-exclusion column-multiangle laser light scattering</p></def></def-item><def-item><term id="G5">AUC</term><def><p>analytical ultracentrifugation</p></def></def-item><def-item><term id="G6">HOO</term><def><p>higher order oligomer</p></def></def-item><def-item><term id="G7">PSV</term><def><p>partial specific volume</p></def></def-item><def-item><term id="G8">AM/MM</term><def><p>average mass/monomer mass.</p></def></def-item></def-list></p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgments</title>
      <p>We thank Adam Huffman (Bioinformatics), Paul Fullwood (DNA Sequencing), Dr. Patrick Bryant (Crystallography), and the EM Facility Staff from the Faculty of Life Sciences, and Dr. Nicoletta Bobola, Faculty of Medical and Human Sciences (University of Manchester, Manchester M13 9PL, United Kingdom); Dr. Manfred Roessle (Deutsches Elektronen-Synchrotron, Hamburg, Germany); and Dr. Rowan Orme (Keele University, Keele, Staffordshire ST5 5BG, United Kingdom).</p>
    </ack>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="B1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Argraves</surname><given-names>W. S.</given-names></name><name><surname>Greene</surname><given-names>L. M.</given-names></name><name><surname>Cooley</surname><given-names>M. A.</given-names></name><name><surname>Gallagher</surname><given-names>W. M.</given-names></name></person-group> (<year>2003</year>) <source>EMBO Rep.</source><volume>4</volume>, <fpage>1127</fpage>â<lpage>1131</lpage><pub-id pub-id-type="pmid">14647206</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>M. L.</given-names></name><name><surname>Tsuda</surname><given-names>T.</given-names></name></person-group> (<year>2004</year>) <source>Birth Defects Res. C. Embryo. Today</source><volume>72</volume>, <fpage>25</fpage>â<lpage>36</lpage><pub-id pub-id-type="pmid">15054902</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Vega</surname><given-names>S.</given-names></name><name><surname>Iwamoto</surname><given-names>T.</given-names></name><name><surname>Yamada</surname><given-names>Y.</given-names></name></person-group> (<year>2009</year>) <source>Cell. Mol. Life Sci.</source><volume>66</volume>, <fpage>1890</fpage>â<lpage>1902</lpage><pub-id pub-id-type="pmid">19189051</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Timpl</surname><given-names>R.</given-names></name><name><surname>Sasaki</surname><given-names>T.</given-names></name><name><surname>Kostka</surname><given-names>G.</given-names></name><name><surname>Chu</surname><given-names>M. L.</given-names></name></person-group> (<year>2003</year>) <source>Nat. Rev. Mol. Cell Biol.</source><volume>4</volume>, <fpage>479</fpage>â<lpage>489</lpage><pub-id pub-id-type="pmid">12778127</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kowal</surname><given-names>R. C.</given-names></name><name><surname>Richardson</surname><given-names>J. A.</given-names></name><name><surname>Miano</surname><given-names>J. M.</given-names></name><name><surname>Olson</surname><given-names>E. N.</given-names></name></person-group> (<year>1999</year>) <source>Circ. Res.</source><volume>84</volume>, <fpage>1166</fpage>â<lpage>1176</lpage><pub-id pub-id-type="pmid">10347091</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>T.</given-names></name><name><surname>Ruiz-Lozano</surname><given-names>P.</given-names></name><name><surname>Lindner</surname><given-names>V.</given-names></name><name><surname>Yabe</surname><given-names>D.</given-names></name><name><surname>Taniwaki</surname><given-names>M.</given-names></name><name><surname>Furukawa</surname><given-names>Y.</given-names></name><name><surname>Kobuke</surname><given-names>K.</given-names></name><name><surname>Tashiro</surname><given-names>K.</given-names></name><name><surname>Lu</surname><given-names>Z.</given-names></name><name><surname>Andon</surname><given-names>N. L.</given-names></name><name><surname>Schaub</surname><given-names>R.</given-names></name><name><surname>Matsumori</surname><given-names>A.</given-names></name><name><surname>Sasayama</surname><given-names>S.</given-names></name><name><surname>Chien</surname><given-names>K. R.</given-names></name><name><surname>Honjo</surname><given-names>T.</given-names></name></person-group> (<year>1999</year>) <source>J. Biol. Chem.</source><volume>274</volume>, <fpage>22476</fpage>â<lpage>22483</lpage><pub-id pub-id-type="pmid">10428823</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kielty</surname><given-names>C. M.</given-names></name><name><surname>Sherratt</surname><given-names>M. J.</given-names></name><name><surname>Shuttleworth</surname><given-names>C. A.</given-names></name></person-group> (<year>2002</year>) <source>J. Cell Sci.</source><volume>115</volume>, <fpage>2817</fpage>â<lpage>2828</lpage><pub-id pub-id-type="pmid">12082143</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>A. J.</given-names></name></person-group> (<year>2001</year>) <source>Mech. Ageing Dev.</source><volume>122</volume>, <fpage>735</fpage>â<lpage>755</lpage><pub-id pub-id-type="pmid">11322995</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>T.</given-names></name><name><surname>Lozano</surname><given-names>P. R.</given-names></name><name><surname>Ikeda</surname><given-names>Y.</given-names></name><name><surname>Iwanaga</surname><given-names>Y.</given-names></name><name><surname>Hinek</surname><given-names>A.</given-names></name><name><surname>Minamisawa</surname><given-names>S.</given-names></name><name><surname>Cheng</surname><given-names>C. F.</given-names></name><name><surname>Kobuke</surname><given-names>K.</given-names></name><name><surname>Dalton</surname><given-names>N.</given-names></name><name><surname>Takada</surname><given-names>Y.</given-names></name><name><surname>Tashiro</surname><given-names>K.</given-names></name><name><surname>Ross</surname><given-names>J.</given-names><suffix>Jr.</suffix></name><name><surname>Honjo</surname><given-names>T.</given-names></name><name><surname>Chien</surname><given-names>K. R.</given-names></name></person-group> (<year>2002</year>) <source>Nature</source><volume>415</volume>, <fpage>171</fpage>â<lpage>175</lpage><pub-id pub-id-type="pmid">11805835</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yanagisawa</surname><given-names>H.</given-names></name><name><surname>Davis</surname><given-names>E. C.</given-names></name><name><surname>Starcher</surname><given-names>B. C.</given-names></name><name><surname>Ouchi</surname><given-names>T.</given-names></name><name><surname>Yanagisawa</surname><given-names>M.</given-names></name><name><surname>Richardson</surname><given-names>J. A.</given-names></name><name><surname>Olson</surname><given-names>E. N.</given-names></name></person-group> (<year>2002</year>) <source>Nature</source><volume>415</volume>, <fpage>168</fpage>â<lpage>171</lpage><pub-id pub-id-type="pmid">11805834</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Claus</surname><given-names>S.</given-names></name><name><surname>Fischer</surname><given-names>J.</given-names></name><name><surname>MÃ©garbanÃ©</surname><given-names>H.</given-names></name><name><surname>MÃ©garbanÃ©</surname><given-names>A.</given-names></name><name><surname>Jobard</surname><given-names>F.</given-names></name><name><surname>Debret</surname><given-names>R.</given-names></name><name><surname>Peyrol</surname><given-names>S.</given-names></name><name><surname>Saker</surname><given-names>S.</given-names></name><name><surname>Devillers</surname><given-names>M.</given-names></name><name><surname>Sommer</surname><given-names>P.</given-names></name><name><surname>Damour</surname><given-names>O.</given-names></name></person-group> (<year>2008</year>) <source>J. Invest. Dermatol.</source><volume>128</volume>, <fpage>1442</fpage>â<lpage>1450</lpage><pub-id pub-id-type="pmid">18185537</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loeys</surname><given-names>B.</given-names></name><name><surname>Van Maldergem</surname><given-names>L.</given-names></name><name><surname>Mortier</surname><given-names>G.</given-names></name><name><surname>Coucke</surname><given-names>P.</given-names></name><name><surname>Gerniers</surname><given-names>S.</given-names></name><name><surname>Naeyaert</surname><given-names>J. M.</given-names></name><name><surname>De Paepe</surname><given-names>A.</given-names></name></person-group> (<year>2002</year>) <source>Hum. Mol. Genet.</source><volume>11</volume>, <fpage>2113</fpage>â<lpage>2118</lpage><pub-id pub-id-type="pmid">12189163</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markova</surname><given-names>D.</given-names></name><name><surname>Zou</surname><given-names>Y.</given-names></name><name><surname>Ringpfeil</surname><given-names>F.</given-names></name><name><surname>Sasaki</surname><given-names>T.</given-names></name><name><surname>Kostka</surname><given-names>G.</given-names></name><name><surname>Timpl</surname><given-names>R.</given-names></name><name><surname>Uitto</surname><given-names>J.</given-names></name><name><surname>Chu</surname><given-names>M. L.</given-names></name></person-group> (<year>2003</year>) <source>Am. J. Hum. Genet.</source><volume>72</volume>, <fpage>998</fpage>â<lpage>1004</lpage><pub-id pub-id-type="pmid">12618961</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lotery</surname><given-names>A. J.</given-names></name><name><surname>Baas</surname><given-names>D.</given-names></name><name><surname>Ridley</surname><given-names>C.</given-names></name><name><surname>Jones</surname><given-names>R. P.</given-names></name><name><surname>Klaver</surname><given-names>C. C.</given-names></name><name><surname>Stone</surname><given-names>E.</given-names></name><name><surname>Nakamura</surname><given-names>T.</given-names></name><name><surname>Luff</surname><given-names>A.</given-names></name><name><surname>Griffiths</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Bergen</surname><given-names>A. A.</given-names></name><name><surname>Trump</surname><given-names>D.</given-names></name></person-group> (<year>2006</year>) <source>Hum. Mutat.</source><volume>27</volume>, <fpage>568</fpage>â<lpage>574</lpage><pub-id pub-id-type="pmid">16652333</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname><given-names>E. M.</given-names></name><name><surname>Braun</surname><given-names>T. A.</given-names></name><name><surname>Russell</surname><given-names>S. R.</given-names></name><name><surname>Kuehn</surname><given-names>M. H.</given-names></name><name><surname>Lotery</surname><given-names>A. J.</given-names></name><name><surname>Moore</surname><given-names>P. A.</given-names></name><name><surname>Eastman</surname><given-names>C. G.</given-names></name><name><surname>Casavant</surname><given-names>T. L.</given-names></name><name><surname>Sheffield</surname><given-names>V. C.</given-names></name></person-group> (<year>2004</year>) <source>N. Engl. J. Med.</source><volume>351</volume>, <fpage>346</fpage>â<lpage>353</lpage><pub-id pub-id-type="pmid">15269314</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirai</surname><given-names>M.</given-names></name><name><surname>Ohbayashi</surname><given-names>T.</given-names></name><name><surname>Horiguchi</surname><given-names>M.</given-names></name><name><surname>Okawa</surname><given-names>K.</given-names></name><name><surname>Hagiwara</surname><given-names>A.</given-names></name><name><surname>Chien</surname><given-names>K. R.</given-names></name><name><surname>Kita</surname><given-names>T.</given-names></name><name><surname>Nakamura</surname><given-names>T.</given-names></name></person-group> (<year>2007</year>) <source>J. Cell Biol.</source><volume>176</volume>, <fpage>1061</fpage>â<lpage>1071</lpage><pub-id pub-id-type="pmid">17371835</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>L. J.</given-names></name><name><surname>Lomas</surname><given-names>A.</given-names></name><name><surname>Hodson</surname><given-names>N.</given-names></name><name><surname>Sherratt</surname><given-names>M. J.</given-names></name><name><surname>Mellody</surname><given-names>K. T.</given-names></name><name><surname>Weiss</surname><given-names>A. S.</given-names></name><name><surname>Shuttleworth</surname><given-names>A.</given-names></name><name><surname>Kielty</surname><given-names>C. M.</given-names></name></person-group> (<year>2005</year>) <source>Biochem. J.</source><volume>388</volume>, <fpage>1</fpage>â<lpage>5</lpage><pub-id pub-id-type="pmid">15790312</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <label>18.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Gao</surname><given-names>J.</given-names></name><name><surname>Pawlyk</surname><given-names>B.</given-names></name><name><surname>Starcher</surname><given-names>B.</given-names></name><name><surname>Spencer</surname><given-names>J. A.</given-names></name><name><surname>Yanagisawa</surname><given-names>H.</given-names></name><name><surname>Zuo</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>T.</given-names></name></person-group> (<year>2004</year>) <source>Nat. Genet.</source><volume>36</volume>, <fpage>178</fpage>â<lpage>182</lpage><pub-id pub-id-type="pmid">14745449</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirai</surname><given-names>M.</given-names></name><name><surname>Horiguchi</surname><given-names>M.</given-names></name><name><surname>Ohbayashi</surname><given-names>T.</given-names></name><name><surname>Kita</surname><given-names>T.</given-names></name><name><surname>Chien</surname><given-names>K. R.</given-names></name><name><surname>Nakamura</surname><given-names>T.</given-names></name></person-group> (<year>2007</year>) <source>EMBO J.</source><volume>26</volume>, <fpage>3283</fpage>â<lpage>3295</lpage><pub-id pub-id-type="pmid">17581631</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zanetti</surname><given-names>M.</given-names></name><name><surname>Braghetta</surname><given-names>P.</given-names></name><name><surname>Sabatelli</surname><given-names>P.</given-names></name><name><surname>Mura</surname><given-names>I.</given-names></name><name><surname>Doliana</surname><given-names>R.</given-names></name><name><surname>Colombatti</surname><given-names>A.</given-names></name><name><surname>Volpin</surname><given-names>D.</given-names></name><name><surname>Bonaldo</surname><given-names>P.</given-names></name><name><surname>Bressan</surname><given-names>G. M.</given-names></name></person-group> (<year>2004</year>) <source>Mol. Cell. Biol.</source><volume>24</volume>, <fpage>638</fpage>â<lpage>650</lpage><pub-id pub-id-type="pmid">14701737</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <label>21.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapetanopoulos</surname><given-names>A.</given-names></name><name><surname>Fresser</surname><given-names>F.</given-names></name><name><surname>Millonig</surname><given-names>G.</given-names></name><name><surname>Shaul</surname><given-names>Y.</given-names></name><name><surname>Baier</surname><given-names>G.</given-names></name><name><surname>Utermann</surname><given-names>G.</given-names></name></person-group> (<year>2002</year>) <source>Mol. Genet. Genomics</source><volume>267</volume>, <fpage>440</fpage>â<lpage>446</lpage><pub-id pub-id-type="pmid">12111551</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <label>22.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>A. D.</given-names></name><name><surname>Itoh</surname><given-names>S.</given-names></name><name><surname>Jeney</surname><given-names>V.</given-names></name><name><surname>Yanagisawa</surname><given-names>H.</given-names></name><name><surname>Fujimoto</surname><given-names>M.</given-names></name><name><surname>Ushio-Fukai</surname><given-names>M.</given-names></name><name><surname>Fukai</surname><given-names>T.</given-names></name></person-group> (<year>2004</year>) <source>Circ. Res.</source><volume>95</volume>, <fpage>1067</fpage>â<lpage>1074</lpage><pub-id pub-id-type="pmid">15528465</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <label>23.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lomas</surname><given-names>A. C.</given-names></name><name><surname>Mellody</surname><given-names>K. T.</given-names></name><name><surname>Freeman</surname><given-names>L. J.</given-names></name><name><surname>Bax</surname><given-names>D. V.</given-names></name><name><surname>Shuttleworth</surname><given-names>C. A.</given-names></name><name><surname>Kielty</surname><given-names>C. M.</given-names></name></person-group> (<year>2007</year>) <source>Biochem. J.</source><volume>405</volume>, <fpage>417</fpage>â<lpage>428</lpage><pub-id pub-id-type="pmid">17472576</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <label>24.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wachi</surname><given-names>H.</given-names></name><name><surname>Nonaka</surname><given-names>R.</given-names></name><name><surname>Sato</surname><given-names>F.</given-names></name><name><surname>Shibata-Sato</surname><given-names>K.</given-names></name><name><surname>Ishida</surname><given-names>M.</given-names></name><name><surname>Iketani</surname><given-names>S.</given-names></name><name><surname>Maeda</surname><given-names>I.</given-names></name><name><surname>Okamoto</surname><given-names>K.</given-names></name><name><surname>Urban</surname><given-names>Z.</given-names></name><name><surname>Onoue</surname><given-names>S.</given-names></name><name><surname>Seyama</surname><given-names>Y.</given-names></name></person-group> (<year>2008</year>) <source>J. Biochem.</source><volume>143</volume>, <fpage>633</fpage>â<lpage>639</lpage><pub-id pub-id-type="pmid">18267938</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <label>25.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cirulis</surname><given-names>J. T.</given-names></name><name><surname>Bellingham</surname><given-names>C. M.</given-names></name><name><surname>Davis</surname><given-names>E. C.</given-names></name><name><surname>Hubmacher</surname><given-names>D.</given-names></name><name><surname>Reinhardt</surname><given-names>D. P.</given-names></name><name><surname>Mecham</surname><given-names>R. P.</given-names></name><name><surname>Keeley</surname><given-names>F. W.</given-names></name></person-group> (<year>2008</year>) <source>Biochemistry</source><volume>47</volume>, <fpage>12601</fpage>â<lpage>12613</lpage><pub-id pub-id-type="pmid">18973305</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <label>26.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>N.</given-names></name><name><surname>Kostka</surname><given-names>G.</given-names></name><name><surname>Garbe</surname><given-names>J. H.</given-names></name><name><surname>Keene</surname><given-names>D. R.</given-names></name><name><surname>BÃ¤chinger</surname><given-names>H. P.</given-names></name><name><surname>Hanisch</surname><given-names>F. G.</given-names></name><name><surname>Markova</surname><given-names>D.</given-names></name><name><surname>Tsuda</surname><given-names>T.</given-names></name><name><surname>Timpl</surname><given-names>R.</given-names></name><name><surname>Chu</surname><given-names>M. L.</given-names></name><name><surname>Sasaki</surname><given-names>T.</given-names></name></person-group> (<year>2007</year>) <source>J. Biol. Chem.</source><volume>282</volume>, <fpage>11805</fpage>â<lpage>11816</lpage><pub-id pub-id-type="pmid">17324935</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <label>27.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golovanov</surname><given-names>A. P.</given-names></name><name><surname>Hautbergue</surname><given-names>G. M.</given-names></name><name><surname>Wilson</surname><given-names>S. A.</given-names></name><name><surname>Lian</surname><given-names>L. Y.</given-names></name></person-group> (<year>2004</year>) <source>J. Am. Chem. Soc.</source><volume>126</volume>, <fpage>8933</fpage>â<lpage>8939</lpage><pub-id pub-id-type="pmid">15264823</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <label>28.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ludtke</surname><given-names>S. J.</given-names></name><name><surname>Baldwin</surname><given-names>P. R.</given-names></name><name><surname>Chiu</surname><given-names>W.</given-names></name></person-group> (<year>1999</year>) <source>J. Struct. Biol.</source><volume>128</volume>, <fpage>82</fpage>â<lpage>97</lpage><pub-id pub-id-type="pmid">10600563</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <label>29.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Heel</surname><given-names>M.</given-names></name><name><surname>Harauz</surname><given-names>G.</given-names></name><name><surname>Orlova</surname><given-names>E. V.</given-names></name><name><surname>Schmidt</surname><given-names>R.</given-names></name><name><surname>Schatz</surname><given-names>M.</given-names></name></person-group> (<year>1996</year>) <source>J. Struct. Biol.</source><volume>116</volume>, <fpage>17</fpage>â<lpage>24</lpage><pub-id pub-id-type="pmid">8742718</pub-id></mixed-citation>
      </ref>
      <ref id="B30">
        <label>30.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>J.</given-names></name><name><surname>Shimkin</surname><given-names>B.</given-names></name><name><surname>Dowse</surname><given-names>H.</given-names></name></person-group> (<year>1981</year>) <source>Ultramicroscopy</source><volume>6</volume>, <fpage>343</fpage>â<lpage>357</lpage></mixed-citation>
      </ref>
      <ref id="B31">
        <label>31.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roessle</surname><given-names>M. W.</given-names></name><name><surname>Klaering</surname><given-names>R.</given-names></name><name><surname>Ristau</surname><given-names>U.</given-names></name><name><surname>Robrahn</surname><given-names>B.</given-names></name><name><surname>Jahn</surname><given-names>D.</given-names></name><name><surname>Gehrmann</surname><given-names>T.</given-names></name><name><surname>Konarev</surname><given-names>P.</given-names></name><name><surname>Round</surname><given-names>A.</given-names></name><name><surname>Fiedler</surname><given-names>S.</given-names></name><name><surname>Hermes</surname><given-names>C.</given-names></name><name><surname>Svergun</surname><given-names>D.</given-names></name></person-group> (<year>2007</year>) <source>J. Appl. Crystallogr.</source><volume>40</volume>, <fpage>S190</fpage>â<lpage>S194</lpage></mixed-citation>
      </ref>
      <ref id="B32">
        <label>32.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semenyuk</surname><given-names>A. V.</given-names></name><name><surname>Svergun</surname><given-names>D. I.</given-names></name></person-group> (<year>1991</year>) <source>J. Appl. Crystallogr.</source><volume>24</volume>, <fpage>537</fpage>â<lpage>540</lpage></mixed-citation>
      </ref>
      <ref id="B33">
        <label>33.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Svergun</surname><given-names>D. I.</given-names></name><name><surname>Petoukhov</surname><given-names>M. V.</given-names></name><name><surname>Koch</surname><given-names>M. H. J.</given-names></name></person-group> (<year>2001</year>) <source>Biophys. J.</source><volume>80</volume>, <fpage>2946</fpage>â<lpage>2953</lpage><pub-id pub-id-type="pmid">11371467</pub-id></mixed-citation>
      </ref>
      <ref id="B34">
        <label>34.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volkov</surname><given-names>V. V.</given-names></name><name><surname>Svergun</surname><given-names>D. I.</given-names></name></person-group> (<year>2003</year>) <source>J. Appl. Crystallogr.</source><volume>36</volume>, <fpage>860</fpage>â<lpage>864</lpage></mixed-citation>
      </ref>
      <ref id="B35">
        <label>35.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitmore</surname><given-names>L.</given-names></name><name><surname>Wallace</surname><given-names>B. A.</given-names></name></person-group> (<year>2004</year>) <source>Nucleic Acids Res.</source><volume>32</volume>, <fpage>W668</fpage>â<lpage>W673</lpage><pub-id pub-id-type="pmid">15215473</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <label>36.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Compton</surname><given-names>L. A.</given-names></name><name><surname>Johnson</surname><given-names>W. C.</given-names><suffix>Jr.</suffix></name></person-group> (<year>1986</year>) <source>Anal. Biochem.</source><volume>155</volume>, <fpage>155</fpage>â<lpage>167</lpage><pub-id pub-id-type="pmid">3717552</pub-id></mixed-citation>
      </ref>
      <ref id="B37">
        <label>37.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>D.</given-names></name><name><surname>Laue</surname><given-names>T.</given-names></name><name><surname>Philo</surname><given-names>J.</given-names></name></person-group> (<year>1995</year>) <source>Program Sednterp: Sedimentation Interpretation Program</source>, <publisher-name>Alliance Protein Laboratories</publisher-name>, <publisher-loc>Thousand Oaks, CA</publisher-loc></mixed-citation>
      </ref>
      <ref id="B38">
        <label>38.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>M. S.</given-names></name><name><surname>Junghans</surname><given-names>R. P.</given-names></name></person-group> (<year>2000</year>) <source>Methods Enzymol.</source><volume>321</volume>, <fpage>136</fpage>â<lpage>149</lpage><pub-id pub-id-type="pmid">10909055</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <label>39.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuck</surname><given-names>P.</given-names></name></person-group> (<year>2000</year>) <source>Biophys. J.</source><volume>78</volume>, <fpage>1606</fpage>â<lpage>1619</lpage><pub-id pub-id-type="pmid">10692345</pub-id></mixed-citation>
      </ref>
      <ref id="B40">
        <label>40.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vistica</surname><given-names>J.</given-names></name><name><surname>Dam</surname><given-names>J.</given-names></name><name><surname>Balbo</surname><given-names>A.</given-names></name><name><surname>Yikilmaz</surname><given-names>E.</given-names></name><name><surname>Mariuzza</surname><given-names>R. A.</given-names></name><name><surname>Rouault</surname><given-names>T. A.</given-names></name><name><surname>Schuck</surname><given-names>P.</given-names></name></person-group> (<year>2004</year>) <source>Anal. Biochem.</source><volume>326</volume>, <fpage>234</fpage>â<lpage>256</lpage><pub-id pub-id-type="pmid">15003564</pub-id></mixed-citation>
      </ref>
      <ref id="B41">
        <label>41.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>W. C.</given-names><suffix>Jr.</suffix></name></person-group> (<year>1990</year>) <source>Proteins Struct. Funct. Genet.</source><volume>7</volume>, <fpage>205</fpage>â<lpage>214</lpage><pub-id pub-id-type="pmid">2194218</pub-id></mixed-citation>
      </ref>
      <ref id="B42">
        <label>42.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de la Torre</surname><given-names>J. G.</given-names></name><name><surname>Llorca</surname><given-names>O.</given-names></name><name><surname>Carrascosa</surname><given-names>J. L.</given-names></name><name><surname>Valpuesta</surname><given-names>J. M.</given-names></name></person-group> (<year>2001</year>) <source>Eur. Biophys. J. Biophys. Lett.</source><volume>30</volume>, <fpage>457</fpage>â<lpage>462</lpage></mixed-citation>
      </ref>
      <ref id="B43">
        <label>43.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>GarcÃ­a De La Torre</surname><given-names>J.</given-names></name><name><surname>Huertas</surname><given-names>M. L.</given-names></name><name><surname>Carrasco</surname><given-names>B.</given-names></name></person-group> (<year>2000</year>) <source>Biophys. J.</source><volume>78</volume>, <fpage>719</fpage>â<lpage>730</lpage><pub-id pub-id-type="pmid">10653785</pub-id></mixed-citation>
      </ref>
      <ref id="B44">
        <label>44.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Downing</surname><given-names>A. K.</given-names></name><name><surname>Knott</surname><given-names>V.</given-names></name><name><surname>Werner</surname><given-names>J. M.</given-names></name><name><surname>Cardy</surname><given-names>C. M.</given-names></name><name><surname>Campbell</surname><given-names>I. D.</given-names></name><name><surname>Handford</surname><given-names>P. A.</given-names></name></person-group> (<year>1996</year>) <source>Cell</source><volume>85</volume>, <fpage>597</fpage>â<lpage>605</lpage><pub-id pub-id-type="pmid">8653794</pub-id></mixed-citation>
      </ref>
      <ref id="B45">
        <label>45.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>Z.</given-names></name><name><surname>Handford</surname><given-names>P.</given-names></name><name><surname>Mayhew</surname><given-names>M.</given-names></name><name><surname>Knott</surname><given-names>V.</given-names></name><name><surname>Brownlee</surname><given-names>G. G.</given-names></name><name><surname>Stuart</surname><given-names>D.</given-names></name></person-group> (<year>1995</year>) <source>Cell</source><volume>82</volume>, <fpage>131</fpage>â<lpage>141</lpage><pub-id pub-id-type="pmid">7606779</pub-id></mixed-citation>
      </ref>
      <ref id="B46">
        <label>46.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hope</surname><given-names>R. A.</given-names></name></person-group> (<year>1993</year>) <source>Oxford Handbook of Clinical Medicine</source> (
<person-group person-group-type="editor"><name><surname>Hope</surname><given-names>R. A.</given-names></name><name><surname>Longmore</surname><given-names>J. M.</given-names></name><name><surname>Hodgetts</surname><given-names>T. J.</given-names></name><name><surname>Ramrakha</surname><given-names>T. S.</given-names></name></person-group> eds) <edition>3rd Ed.</edition>, <publisher-name>Oxford University Press</publisher-name>, <publisher-loc>Oxford, UK</publisher-loc></mixed-citation>
      </ref>
      <ref id="B47">
        <label>47.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinhardt</surname><given-names>D. P.</given-names></name><name><surname>Ono</surname><given-names>R. N.</given-names></name><name><surname>Sakai</surname><given-names>L. Y.</given-names></name></person-group> (<year>1997</year>) <source>J. Biol. Chem.</source><volume>272</volume>, <fpage>1231</fpage>â<lpage>1236</lpage><pub-id pub-id-type="pmid">8995426</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>